NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDDupilumab Dupixent®
(For severe asthma with type 2 inflammation) 		Respiratory system, Allergen Immunotherapy, 03.04.02
REDDupilumab Dupixent®
(For severe atopic eczema) 		Skin, Drugs affecting the immune response, 13.05.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Dupilumab Dupilumab Nose, Nasal Inflammation, Nasal Polyps And Rhinitis, Immunosuppressants Interleukin Inhibitors
Dupilumab Dupilumab Respiratory System, Airways Disease, Obstructive, Immunosuppressants Interleukin Inhibitors
Dupilumab Dupilumab Skin, Inflammatory Skin Conditions, Eczema And Psoriasis, Immunosuppressants Interleukin Inhibitors
Dupilumab Dupilumab Skin, Pruritus, Immunosuppressants Interleukin Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
MHRA DSU Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management
MHRA DSU: Dupilumab (Dupixent▼): risk of ocular adverse reactions and need for prompt management
NICE TA 751 Dupilumab for treating severe asthma with type 2 inflammation
NICE TA534: Dupilumab for treating moderate to severe atopic dermatitis
NICE TA955: Dupilumab for treating moderate to severe prurigo nodularis (NOT RECOMMENDED)